Analysis of the adoption of new health technology: the case of Dupuytren's disease
by Riikka-Leena Leskelä; Fredrik Herse; Paulus Torkki; Juha Laine; Tiina Vilkuna; Timo Raatikainen
International Journal of Healthcare Technology and Management (IJHTM), Vol. 15, No. 3, 2016

Abstract: Health technology assessment focuses on clinical effectiveness and cost efficiency, but achieving these goals does not guarantee the adoption of a new technology if the incentives of individual decision makers (payers, patients, providers) are not aligned. This study creates a framework for the analysis of the adoption phase. The framework is tested in the case of a new, non-invasive treatment for Dupuytren's disease. The framework is developed based on existing operations management theories. The cost-benefit analysis in the case study utilises information on the Finnish healthcare system, detailed data on the process of the surgical and treatment for Dupuytren's from seven hospital districts and expert interviews on the non-surgical treatment process. The analysis suggests that the new technology will most likely be adopted, but it also shows that there are potential hindrances. The study shows that it is important to consider the incentives of individual operators within the healthcare system.

Online publication date: Mon, 15-Aug-2016

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Healthcare Technology and Management (IJHTM):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com